These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34720312)

  • 41. Use of mouthwashes against COVID-19 in dentistry.
    Vergara-Buenaventura A; Castro-Ruiz C
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.
    Sirijatuphat R; Leelarasamee A; Puangpet T; Thitithanyanont A
    Infect Drug Resist; 2022; 15():7529-7536. PubMed ID: 36575672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro comparison of the tensile strength of elastomeric ligatures exposed to Povidone Iodine 1%, Chlorhexidine 0.02%, and hydrogen peroxide 5.
    Ebrahiminik Z; Zanganeh M; Salari B; Fadaee N; Mirshahpanah M
    Int Orthod; 2021 Dec; 19(4):685-688. PubMed ID: 34688569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
    Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
    J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Rifampin, Povidone-Iodine and Hydrogen Peroxide on the Formation of Epidural Fibrosis in the Experimental Epidural Fibrosis Model.
    Kizilay Z; Cetin NK; İsmailoglu Ö; Yılmaz A; Omurlu İK; Coskun ME; Aktaş S
    Inflammation; 2016 Aug; 39(4):1495-502. PubMed ID: 27251380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
    Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ
    J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stable thyroid function despite regular use of povidone-iodine throat spray for SARS-CoV-2 prophylaxis.
    Quek AML; Ng MY; Teng O; Lim NA; Ng GJL; Yang SP; Hartman M; Tambyah PA; Cook AR; Seet RCS
    Ann Med; 2022 Dec; 54(1):3299-3305. PubMed ID: 36399104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces.
    Yamasaki K; Mizuno Y; Kitamura Y; McCanna DJ; Ngo W; Jones LW
    Cont Lens Anterior Eye; 2021 Feb; 44(1):18-23. PubMed ID: 32115355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
    Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.
    Hasan MJ; Rumi SKNF; Banu SS; Uddin AKMN; Islam MS; Arefin MK
    Trials; 2021 Jan; 22(1):2. PubMed ID: 33397432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial.
    Chaudhary P; Melkonyan A; Meethil A; Saraswat S; Hall DL; Cottle J; Wenzel M; Ayouty N; Bense S; Casanova F; Chaney M; Chase H; Hermel R; McClement M; Sesson C; Woolsey B; Kumar P
    J Am Dent Assoc; 2021 Nov; 152(11):903-908. PubMed ID: 34561086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial.
    Seet RCS; Quek AML; Ooi DSQ; Sengupta S; Lakshminarasappa SR; Koo CY; So JBY; Goh BC; Loh KS; Fisher D; Teoh HL; Sun J; Cook AR; Tambyah PA; Hartman M
    Int J Infect Dis; 2021 May; 106():314-322. PubMed ID: 33864917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of three commercial mouth rinses on cultured human gingival fibroblast: an in vitro study.
    Flemingson ; Emmadi P; Ambalavanan N; Ramakrishnan T; Vijayalakshmi R
    Indian J Dent Res; 2008; 19(1):29-35. PubMed ID: 18245921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.
    Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics?
    Burgos-Ramos E; Urbieta IR; Rodríguez D
    Saudi Dent J; 2022 Mar; 34(3):237-242. PubMed ID: 35136326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19.
    Guimarães TC; Marques BBF; Castro MV; Secco DA; Porto LCMS; Tinoco JMM; Tinoco EMB; Fletcher P; Fischer RG
    Oral Dis; 2022 Nov; 28 Suppl 2():2474-2480. PubMed ID: 34963033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.